Combined Signature of the Fecal Microbiome and Plasma Metabolome in Patients with Ulcerative Colitis

Abstract

Background Ulcerative colitis is a chronic, idiopathic inflammatory disease that destroys the colon structure. Nevertheless, the exact pathogenesis is not clear and needs to be fully elucidated. Material/Methods Stool and plasma samples were used for 16S ribosomal RNA sequencing and liquid chromatography mass spectrometry, respectively. In addition, we detected the level of trimethylamine N-oxide. Finally, we performed Pearson correlation analysis between the microbiome and the metabolome. Results Twenty-three active ulcerative colitis, 25 inactive ulcerative colitis, and 30 control cases were included. Thirty-four significantly different metabolites were found between the active ulcerative colitis and control groups, 38 were found between the inactive ulcerative colitis and control groups, and only 1 was found between the active ulcerative colitis and inactive ulcerative colitis groups. The plasma trimethylamine N-oxide level of the inactive ulcerative colitis and active ulcerative colitis groups was significantly higher than that of the control group. Moreover, we identified significant changes in 24, 18, and 12 bacterial genera for active ulcerative colitis-control, inactive ulcerative colitis-control, and active ulcerative colitis-inactive ulcerative colitis, respectively. Cross-correlation indicated an association between sphingosine 1-phosphate and Roseburia, Klebsiella, and Escherichia-Shigella. Through the pathway analysis, we found sphingolipid metabolism was one of the most significantly increased pathways. Conclusions Although levels of trimethylamine N-oxide were higher in ulcerative colitis patients, they did not achieve statistical significance in active ulcerative colitis and inactive ulcerative colitis groups. Sphingosine 1-phosphate was increased in ulcerative colitis patients and there were several microbiota associated with it. Although further study is still needed, sphingosine 1-phosphate will probably become a new target for treatment of ulcerative colitis.

Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease

“…However, prior IBD microbiome studies have mostly included subjects with an established treatment; of the 143 microbiome studies included herein, only 11 included treatment-naïve patients [ 15 , 66 , 69 , 75 , 81 , 84 , 87 , 93 , 117 , 118 , 123 ], sometimes only on a small subset of the cohort, and only one was conducted prospectively.…”

Plasma microbiome in COVID-19 subjects: an indicator of gut barrier defects and dysbiosis

“…The fecal microbiome has been compared to the plasma metabolome in disease states such as ulcerative colitis where products of sphingolipid metabolism, specifically sphingosine 1phosphate in the blood correlate with Roseburia, Klebsiella, and Escherichia-Shigella 72 .…”

Gut Microbiota and Related Metabolites Were Disturbed in Ulcerative Colitis and Partly Restored After Mesalamine Treatment

“…The important role of gut microbiota in UC has been widely accepted, and disruptions to the microbiome have been implicated in the pathogenesis ( Derikx et al, 2016 ). A recent study of fecal microbiota analysis revealed that the relative abundance of Escherichia-shigella and Streptococcus was elevated, whereas Bacteroides and Prevotella_9 was reduced in UC patients compared to healthy participants ( Sun et al, 2019 ). Another study reported the gut microbial dysbiosis in Chinese inflammatory bowel disease patients, and found that the community of Megamonas and Butyricicoccus , which could produce short-chain fatty acids and modulate colonic regulatory T cells, was significantly repressed in UC patients stool samples ( Ma et al, 2018 ).…”